Blue light-emitting diode therapy for recurrent vulvovaginal candidiasis: a Brazilian report.

IF 2.1 4区医学 Q3 ENGINEERING, BIOMEDICAL Lasers in Medical Science Pub Date : 2025-01-18 DOI:10.1007/s10103-025-04283-4

Waleska Modesto, Claudia Frederice, Marcela Bardin

{"title":"Blue light-emitting diode therapy for recurrent vulvovaginal candidiasis: a Brazilian report.","authors":"Waleska Modesto, Claudia Frederice, Marcela Bardin","doi":"10.1007/s10103-025-04283-4","DOIUrl":null,"url":null,"abstract":"Purpose: RVVC is defined as four or more episodes of candidiasis in a 12-month period. Conventional treatment is complex and often involves long-term medication use or multiple treatments. ABL therapy is a promising treatment option as it is acceptable to women and has only rare side effects. We conducted a prospective study with the objective of assessing the effects of antimicrobial blue light (ABL) therapy for recurrent vulvovaginal candidiasis (RVVC) in drug-resistant women.Methods: Our study enrolled RVVC drug-resistant women (defined based on clinical non-response to standard azole therapies confirmed through culture or persistence of VVC symptoms (oedema, erythema, pruritus, burning, dysuria and leucorrhea)), who received ABL through 10 sessions for 20 min once a week from January 2023 to January 2024. The symptoms of Recurent VVC were assessed after 10 treatment sections and after 6 months.Results: We included 62 patients. The overall symptoms improvement were 79% immediately after treatment and 58% after 6 months, respectively. There was an improvement in the symptoms of pruritus, burning, oedema, erythema and leucorrhoea.Conclusion: ABL was an effective therapy to be employed in drug-resistant women suffering from RVVC.","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"21"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lasers in Medical Science","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10103-025-04283-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: RVVC is defined as four or more episodes of candidiasis in a 12-month period. Conventional treatment is complex and often involves long-term medication use or multiple treatments. ABL therapy is a promising treatment option as it is acceptable to women and has only rare side effects. We conducted a prospective study with the objective of assessing the effects of antimicrobial blue light (ABL) therapy for recurrent vulvovaginal candidiasis (RVVC) in drug-resistant women.

Methods: Our study enrolled RVVC drug-resistant women (defined based on clinical non-response to standard azole therapies confirmed through culture or persistence of VVC symptoms (oedema, erythema, pruritus, burning, dysuria and leucorrhea)), who received ABL through 10 sessions for 20 min once a week from January 2023 to January 2024. The symptoms of Recurent VVC were assessed after 10 treatment sections and after 6 months.

Results: We included 62 patients. The overall symptoms improvement were 79% immediately after treatment and 58% after 6 months, respectively. There was an improvement in the symptoms of pruritus, burning, oedema, erythema and leucorrhoea.

Conclusion: ABL was an effective therapy to be employed in drug-resistant women suffering from RVVC.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

蓝色发光二极管治疗复发性外阴阴道念珠菌病：巴西报告。

目的：RVVC被定义为在12个月内出现4次或以上念珠菌病发作。传统的治疗方法很复杂，通常需要长期用药或多种治疗。ABL疗法是一种很有前途的治疗选择，因为它对女性来说是可以接受的，而且副作用很少。我们进行了一项前瞻性研究，目的是评估抗菌蓝光（ABL）治疗耐药女性复发性外阴阴道念珠菌病（RVVC）的效果。方法：我们的研究招募了RVVC耐药女性（通过培养或VVC症状（水肿、红斑、瘙痒、灼烧、排尿困难和白带）持续存在，证实临床对标准唑治疗无反应），她们从2023年1月至2024年1月接受ABL治疗，每周一次，每次20分钟，共10次。10次治疗后及6个月后评估复发性VVC的症状。结果：纳入62例患者。治疗后立即和6个月后的总体症状改善分别为79%和58%。瘙痒、灼烧、水肿、红斑和白带等症状均有改善。结论：ABL是治疗RVVC耐药妇女的有效方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Lasers in Medical Science 医学-工程：生物医学

CiteScore

4.50

自引率

4.80%

发文量

192

审稿时长

3-8 weeks

期刊介绍： Lasers in Medical Science (LIMS) has established itself as the leading international journal in the rapidly expanding field of medical and dental applications of lasers and light. It provides a forum for the publication of papers on the technical, experimental, and clinical aspects of the use of medical lasers, including lasers in surgery, endoscopy, angioplasty, hyperthermia of tumors, and photodynamic therapy. In addition to medical laser applications, LIMS presents high-quality manuscripts on a wide range of dental topics, including aesthetic dentistry, endodontics, orthodontics, and prosthodontics. The journal publishes articles on the medical and dental applications of novel laser technologies, light delivery systems, sensors to monitor laser effects, basic laser-tissue interactions, and the modeling of laser-tissue interactions. Beyond laser applications, LIMS features articles relating to the use of non-laser light-tissue interactions.